The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages
Open accessAbstract
Abstract —Macrophages secrete matrix metalloproteinases (MMPs) that may weaken the fibrous cap of atherosclerotic plaque, predisposing its fissuration. The 92-kDa gelatinase B (MMP-9) has been identified in abdominal aortic aneurysms and in atherosclerotic tissues. Fluvastatin, through the inhibition of the isoprenoid pathway, inhibits major processes of atherogenesis in experimental models (smooth muscle cell migration and proliferation and cholesterol accumulation in macrophages). We studied the effect of fluvastatin on the activity of MMP-9 in mouse and human macrophages in culture. Conditioned media of cells treated for 24 hours with fluvastatin were analyzed by gelatin zymography. In mouse macrophages, fluvastatin (5 to 100 μmol/L) significantly inhibited in a dose-dependent manner MMP-9 activity from 20% to 40% versus control. The drug, at a concentration as low as 5 μmol/L, inhibited MMP-9 activity (≈30%) in human monocyte–derived macrophages as well. Phorbol esters (TPA, 50 ng/mL) stimulated MMP-9 activity by 50%, and fluvastatin inhibited this enhanced activity up to 50% in both mouse and human macrophages. The above results on the secretion of MMP-9 were confirmed by Western blotting and ELISA. The inhibitory effect of fluvastatin was overcome by the simultaneous addition of exogenous mevalonate (100 μmol/L), a precursor of isoprenoids. Fluvastatin’s effect was fully reversible, and the drug did not cause any cellular toxicity. The statin did not block directly the in vitro activation of the secreted protease. Similar data were obtained with simvastatin. Altogether, our data indicate an inhibition of MMP-9 secretion by the drug. This effect is mediated by the inhibition of synthesis of mevalonate, a precursor of numerous derivatives essential for several cellular functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
Matrix Metalloproteinases: A Review
Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., & Engler, J. A. (1993) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411930040020401 · Cited by 2,970
PROTEIN PRENYLATION: Molecular Mechanisms and Functional Consequences
Zhang, F. L., & Casey, P. J. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.001325 · Cited by 1,743
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Metalloproteinases and their inhibitors in matrix remodeling
Matrisian, L. M. (1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90126-q · Cited by 1,605
Davies, M. J., Richardson, P. D., Woolf, N., Katz, D. R., & Mann, J. (1993) · Heart · doi:10.1136/hrt.69.5.377 · Cited by 1,127
Matrix Metalloproteinases and Cardiovascular Disease
Dollery, C. M., McEwan, J. R., & Henney, A. M. (1995) · Circulation Research · doi:10.1161/01.res.77.5.863 · Cited by 864
Quantitative Zymography: Detection of Picogram Quantities of Gelatinases
Kleiner, D. E., & Stetlerstevenson, W. G. (1994) · Analytical Biochemistry · doi:10.1006/abio.1994.1186 · Cited by 861
Statins do more than just lower cholesterol
Vaughan, C. J., Murphy, M. B., & Buckley, B. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05190-2 · Cited by 698
Fernández-Ortiz, A., Badimon, J. J., Falk, E., Fuster, V., Meyer, B., Mailhac, A., Weng, D., Shah, P. K., & Badimon, L. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90657-2 · Cited by 587
Bendeck, M. P., Zempo, N., Clowes, A. W., Galardy, R. E., & Reidy, M. A. (1994) · Circulation Research · doi:10.1161/01.res.75.3.539 · Cited by 584
Galis, Z. S., Sukhova, G. K., Kranzhöfer, R., Clark, S., & Libby, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.402 · Cited by 556
Brown, D. L., Hibbs, M. S., Kearney, M., Loushin, C., & Isner, J. M. (1995) · Circulation · doi:10.1161/01.cir.91.8.2125 · Cited by 487
Nagase, H., Enghild, J. J., Suzuki, K., & Salvesen, G. (1990) · Biochemistry · doi:10.1021/bi00476a020 · Cited by 389
Rab GTPases in vesicular transport
Zerial, M., & Stenmark, H. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90130-i · Cited by 381
Retinal degeneration in choroideremia: deficiency of rab geranylgeranyl transferase
Seabra, M. C., Brown, M. S., & Goldstein, J. L. (1993) · Science · doi:10.1126/science.8380507 · Cited by 337
Clowes, A. W., Clowes, M. M., Au, Y. P., Reidy, M. A., & Belin, D. (1990) · Circulation Research · doi:10.1161/01.res.67.1.61 · Cited by 333
Tumor Cell Invasion Inhibited by TIMP-2
Albini, A., Melchiori, A., Santi, L., Liotta, L. A., Brown, P. D., & Stetler-Stevenson, W. G. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.11.775 · Cited by 321
Zempo, N., Koyama, N., Kenagy, R. D., Lea, H. J., & Clowes, A. W. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.1.28 · Cited by 300
Bendeck, M. P., Irvin, C., & Reidy, M. A. (1996) · Circulation Research · doi:10.1161/01.res.78.1.38 · Cited by 297
Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro
Schnaper, H. W., Grant, D. S., Stetler‐Stevenson, W. G., Fridman, R., D'Orazi, G., Murphy, A. N., Bird, R. E., Hoythya, M., Fuerst, T. R., French, D. L., et al. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041560204 · Cited by 289
Soma, M. R., Donetti, E., Parolini, C., Mazzini, G., Ferrari, C., Fumagalli, R., & Paoletti, R. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.4.571 · Cited by 225
Self-citationCorsini, A., Mazzotti, M., Raiteri, M., Soma, M. R., Gabbiani, G., Fumagalli, R., & Paoletti, R. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90107-6 · Cited by 217
Self-citationMNewman, K., YOgata, Malon, A. M., EIrizarry, HGandhi, R., HNagase, & DTilson, M. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · Cited by 186
Burleigh, M. C., Brigfs, A. D., Lendon, C. L., Davies, M. J., Born, G. V. R., & Richardson, P. D. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90039-j · Cited by 159
Sinensky, M., & Lutz, R. J. (1992) · BioEssays · doi:10.1002/bies.950140106 · Cited by 158
Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding.
Botos, I., Scapozza, L., Zhang, D., Liotta, L. A., & Meyer, E. F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2749 · Cited by 138
Expression of activated gelatinase in human invasive breast carcinoma
Brown, P. D., Bloxidge, R. E., Anderson, E. D. C., & Howell, A. (1993) · Clinical & Experimental Metastasis · doi:10.1007/bf00114976 · Cited by 134
James, T. W., Wagner, R. J., White, L. A., Zwolak, R. M., & Brinckerhoff, C. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041570227 · Cited by 109
The extracellular matrix and atherosclerosis
Wight, T. N. (1995) · Current Opinion in Lipidology · doi:10.1097/00041433-199510000-00013 · Cited by 105
Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways
Schnaper, H. W., Barnathan, E. S., Mazar, A. P., Maheshwari, S. R., Ellis, S., Cortez, S. L., Baricos, W. H., & Kleinman, H. K. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041650114 · Cited by 89
Requirement for mevalonate in acetylated LDL induction of cholesterol esterification in macrophages
Bernini, F., Didoni, G., Bonfadini, G., Bellosta, S., & Fumagalli, R. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90172-q · Cited by 79
Self-citationInhibition of Matrix Metalloproteinase 9 Activation by a Specific Monoclonal Antibody
RAMOS‐DeSIMONE, N., Moll, U. M., Quigley, J. P., & French, D. L. (1993) · Hybridoma · doi:10.1089/hyb.1993.12.349 · Cited by 70
Corsini, A., Raiteri, M., Soma, M. R., Bernini, F., Fumagalli, R., & Paoletti, R. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(05)80011-6 · Cited by 64
Self-citationHMG-CoA Reductase Inhibitors Reduce Acetyl LDL Endocytosis in Mouse Peritoneal Macrophages
Bernini, F., Scurati, N., Bonfadini, G., & Fumagalli, R. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1352 · Cited by 46
Self-citationA Study of Dust Toxicity Using a Quantitative Tissue Culture Technique
Marks, J., Mason, M. A., & Nagelschmidt, G. (1956) · Occupational and Environmental Medicine · doi:10.1136/oem.13.3.187 · Cited by 35
Cited by
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,641
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F., & Braunwald, E. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,478
Sakalihasan, N., Limet, R., & Defawe, O. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66459-8 · Cited by 1,152
Beneficial Cardiovascular Pleiotropic Effects of Statins
Davignon, J. (2004) · Circulation · doi:10.1161/01.cir.0000131517.20177.5a · Cited by 955
Metadata
- Authors
- Bellosta, S., Via, D., Canavesi, M., Pfister, P., Fumagalli, R., Paoletti, R., & Bernini, F.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1998-11
- Volume
- 18
- Issue
- 11
- Pages
- 1671-1678
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2060351304
- Cited by
- 512
- References
- 41
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.